Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Proteinuria in children infected with the human immunodeficiency virus.

Chaparro AI, Mitchell CD, Abitbol CL, Wilkinson JD, Baldarrago G, Lopez E, Zilleruelo G.

J Pediatr. 2008 Jun;152(6):844-9. doi: 10.1016/j.jpeds.2007.11.007. Epub 2008 Jan 22.

PMID:
18492529
2.

Predictors of renal outcome in HIV-associated nephropathy.

Post FA, Campbell LJ, Hamzah L, Collins L, Jones R, Siwani R, Johnson L, Fisher M, Holt SG, Bhagani S, Frankel AH, Wilkins E, Ainsworth JG, Larbalestier N, Macallan DC, Banerjee D, Baily G, Thuraisingham RC, Donohoe P, Hendry BM, Hilton RM, Edwards SG, Hangartner R, Howie AJ, Connolly JO, Easterbrook PJ.

Clin Infect Dis. 2008 Apr 15;46(8):1282-9. doi: 10.1086/529385.

PMID:
18444868
3.

Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races.

Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD.

J Infect Dis. 2008 Jun 1;197(11):1548-57. doi: 10.1086/587994.

4.

Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease.

Kalayjian RC, Franceschini N, Gupta SK, Szczech LA, Mupere E, Bosch RJ, Smurzynski M, Albert JM.

AIDS. 2008 Feb 19;22(4):481-7. doi: 10.1097/QAD.0b013e3282f4706d.

5.

Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy.

Goicoechea M, Liu S, Best B, Sun S, Jain S, Kemper C, Witt M, Diamond C, Haubrich R, Louie S; California Collaborative Treatment Group 578 Team.

J Infect Dis. 2008 Jan 1;197(1):102-8. doi: 10.1086/524061.

PMID:
18171292
6.

Increased beta-2 microglobulinuria in human immunodeficiency virus-1-infected children and adolescents treated with tenofovir.

Papaleo A, Warszawski J, Salomon R, Jullien V, Veber F, Dechaux M, Blanche S.

Pediatr Infect Dis J. 2007 Oct;26(10):949-51.

PMID:
17901802
7.

Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children.

Gafni RI, Hazra R, Reynolds JC, Maldarelli F, Tullio AN, DeCarlo E, Worrell CJ, Flaherty JF, Yale K, Kearney BP, Zeichner SL.

Pediatrics. 2006 Sep;118(3):e711-8. Epub 2006 Aug 21.

PMID:
16923923
8.

Incidence of opportunistic and other infections in HIV-infected children in the HAART era.

Gona P, Van Dyke RB, Williams PL, Dankner WM, Chernoff MC, Nachman SA, Seage GR 3rd.

JAMA. 2006 Jul 19;296(3):292-300.

PMID:
16849662
9.

HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients.

Estrella M, Fine DM, Gallant JE, Rahman MH, Nagajothi N, Racusen LC, Scheel PJ, Atta MG.

Clin Infect Dis. 2006 Aug 1;43(3):377-80. Epub 2006 Jun 20.

PMID:
16804855
10.

Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavir.

Hussain S, Khayat A, Tolaymat A, Rathore MH.

Pediatr Nephrol. 2006 Jul;21(7):1034-6. Epub 2006 May 16.

PMID:
16773419
11.

Viral load and HIV-associated nephropathy.

Izzedine H, Wirden M, Launay-Vacher V.

N Engl J Med. 2005 Sep 8;353(10):1072-4. No abstract available.

12.

Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America.

Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, Tashima KT, Roland M, Franceschini N, Palella FJ, Lennox JL, Klotman PE, Nachman SA, Hall SD, Szczech LA.

Clin Infect Dis. 2005 Jun 1;40(11):1559-85. Epub 2005 Apr 22. No abstract available.

PMID:
15889353
13.

Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients.

Gupta SK, Mamlin BW, Johnson CS, Dollins MD, Topf JM, Dubé MP.

Clin Nephrol. 2004 Jan;61(1):1-6.

PMID:
14964451
15.

HIV-associated nephropathy in African Americans.

Kopp JB, Winkler C.

Kidney Int Suppl. 2003 Feb;(83):S43-9. Review.

PMID:
12864874
16.
17.

Fanconi syndrome and renal failure induced by tenofovir: a first case report.

Verhelst D, Monge M, Meynard JL, Fouqueray B, Mougenot B, Girard PM, Ronco P, Rossert J.

Am J Kidney Dis. 2002 Dec;40(6):1331-3.

PMID:
12460055
18.

The epidemiology of end-stage renal disease among African Americans.

Martins D, Tareen N, Norris KC.

Am J Med Sci. 2002 Feb;323(2):65-71. Review.

PMID:
11863081
19.

Observations on HIV-associated renal disease in the era of highly active antiretroviral therapy.

Cosgrove CJ, Abu-Alfa AK, Perazella MA.

Am J Med Sci. 2002 Feb;323(2):102-6.

PMID:
11863077
20.

Microcyst formation and HIV-1 gene expression occur in multiple nephron segments in HIV-associated nephropathy.

Ross MJ, Bruggeman LA, Wilson PD, Klotman PE.

J Am Soc Nephrol. 2001 Dec;12(12):2645-51.

Supplemental Content

Support Center